HBK Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-100,100
Closed -$9.71M 798
2019
Q3
$9.71M Buy
+100,100
New +$10M 0.12% 122
2018
Q3
Sell
-200,100
Closed -$20.5M 1429
2018
Q2
$20.5M Buy
+200,100
New +$15.4M 0.13% 82

HBK Investments's ONCE Position: Q4 2019 in Review

HBK Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 100,100 shares — an estimated $9.71M sold.

HBK Investments first reported a position in ONCE in Q2 2018 and held it in 2 quarters. The position peaked at $20.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • HBK Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • HBK Investments sold 100,100 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $9.71M.
  • HBK Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • HBK Investments's Spark Therapeutics, Inc. Common Stock position peaked at $20.5M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.